ArticleAnnals of translational medicine2021

Liraglutide inhibits the progression of prediabetes in rats by reducing Raf-1 kinase inhibitor protein.

Fei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.